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Background: In persons 15 years and above in South Africa the prevalence of pre-diabetes and diabetes has been
estimated at 9.1% and 9.6%, respectively, and the prevalence of systolic prehypertension and hypertension, 38.2%
and 24.6%, respectively. Elevated blood glucose and elevated blood pressure are prototype of preventable chronic
cardiovascular disease risk factors.
Lifestyle interventions have been shown to control high normal blood pressure and/or high normal blood glucose.
Methods/Design: This study proposes to evaluate the efficacy of a community (church)-based lifestyle intervention
programme to control high normal blood pressure and/or high normal blood glucose in church members in a
randomized controlled trial in Gauteng, South Africa. The objectives are to: (1) measure non-communicable diseases
profile, including hypertension and diabetes, health behaviours, weight management and psychological distress of
church members; (2) measure the reduction of blood glucose and blood pressure levels after the intervention; (3)
prevent the development of impaired glucose tolerance; (4) compare health behaviours, weight management and
psychological distress, blood glucose and blood pressure levels between intervention and control groups, and
within group during 6, 12, 24 and 36 months during and post intervention. The study will use a group-randomized
design, recruiting 300 church members from 12 churches. Churches will be randomly assigned to experimental and
control conditions.
Discussion: Lifestyle interventions may prevent from the development of high blood pressure and/or diabetes. The
findings will impact public health and will enable the health ministry to formulate policy related to lifestyle
interventions to control blood pressure and glucose.
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In the first South African National Health and Nutrition
Examination Survey (SANHANES-1) [1] of 2012, a preva-
lence of 9.1% and 9.6% of prediabetes and diabetes in per-
sons 15 years and above, respectively was found. In the
age groups 35–44, 45–54, 55–64, and 65 years and more,
the prevalence of prediabetes increased from 9.0%, 11.2%,
13.9% to 19.9%, while diabetes was 4.3%, 16.7%, 24.4% and
19.0%, respectively. In the same SANHANES-1 [1], a
prevalence of 38.2% and 20.0% systolic and diastolic pre-
hypertensive blood pressure, respectively, and 24.6% and
9.1% systolic and diastolic hypertension, respectively, in
persons 15 years and above was found. In the age groups
35–44, 45–54, 55–64, and 65 years and more, the preva-
lence of systolic prehypertension was 45.2%, 37.1%, 31.7%
and 24.3%, respectively, and the prevalence of systolic
hypertension was 21.9%, 39.2%, 50.5% and 63.7%, respect-
ively. Elevated blood glucose and elevated blood pressure
are prototype of preventable chronic cardiovascular dis-
ease risk factors [2].
Lifestyle interventions have been shown to ameliorate
or prevent the progression of prediabetes and prehyper-
tension to diabetes and hypertension [3,4]. Such a non-
pharmacological approach to primary prevention and
disease interruption carries enormous public health sig-
nificance [3]. Improving diet and physical activity can pre-
vent type 2 diabetes among those at high risk in a very
short time [5]. In trials conducted in China, Finland and
the USA, for example, study participants have significantly
improved their diet and/or physical activity, and shown
improved levels of blood pressure, blood glucose, choles-
terol and triglycerides within one year of commencing a
programme, with improvements continuing for at least six
years. The incidence of diabetes was reduced by almost
60% in both Finland and the USA, and by over 30% in
China [6,7]. Orozco et al. [8] conclude that interventions
aimed at increasing exercise combined with diet are able
to decrease the incidence of type 2 diabetes in high risk
groups (people with impaired glucose tolerance or the
metabolic syndrome). Likewise, lifestyle modifications can
reduce blood pressure and lower cardiovascular risk.
Several clinical trials investigated the efficacy of non-
pharmacological interventions and lifestyle modifications
to reduce BP. Best evidence from randomized controlled
trials supports BP-lowering effects of weight loss, the Diet-
ary Approaches to Stop Hypertension (DASH) diet, and
dietary sodium (Na+) reduction in those with prehyper-
tension [9]. Established recommendations include weight
loss, sodium reduction, and increased physical activity.
PREMIER studied the effects of lifestyle interventions
based on established recommendations alone and with the
addition of the Dietary Approaches to Stop Hypertension
(DASH) dietary pattern [10]. Participants with prehyper-
tension or stage-1 hypertension were randomly assignedto an advice only control group, a 6-month intensive be-
havioural intervention group of established recommen-
dations (EST), or an established recommendations plus
DASH group (EST +DASH). Both EST and EST +DASH
reduced the primary outcome variable, systolic blood
pressure [10]. Maruthur et al. [11] studied the effect of
PREMIER on estimated coronary heart disease (CHD) risk
and observed substantial reductions of 12% to 14% in esti-
mated CHD risk, which have important public health ben-
efits. Márquez-Celedonio et al. [12] also found in a study
in Mexico that lifestyle modification decreased cardio-
vascular disease risk in individuals with prehypertension.
Prehypertension, defined as blood pressure between 120-
139/80-89 mmHg, is a major public health concern [13].
The condition is very prevalent (30% of the adult popula-
tion), is often associated with other cardiovascular disease
risk factors and independently increases the risk of hyper-
tension and subsequent cardiovascular events [13]. The
mechanism of elevated risk for cardiovascular events asso-
ciated with prehypertension is presumed to be the same as
that of hypertension [13]. The Seventh Report of the Joint
National Committee on Hypertension recommended only
lifestyle changes for most prehypertensive patients [14].
To have a significant public health impact, benefits of
proven lifestyle interventions have to be translated into
community settings [15,16]. Evidence from a varied com-
munity, including church-based settings have shown that
lifestyle interventions can be effective in lowering diabetes
and hypertension risk. Ackerman et al. [17] found positive
results in an implementation, evaluation of the delivery of
a group-based Diabetes Prevention Programme (DPP) life-
style intervention in a community setting. Boltri et al. [18]
describes the successful translation of the National Insti-
tutes of Health Diabetes Prevention Programme (DPP) in
African American churches. A 6-session modified DPP
was associated with decreased fasting glucose and weight
similar to the 16-session programme. Simmons et al. [19,20]
was able to reduce risk factors for diabetes among Western
Samoans in New Zealand based on a church-based
programme. Likewise, Oexmann et al. [21] describes a
successful church-based approach to lifestyle change in
cardiovascular disease risk in African Americans. The
church is an important community intervention setting
for health promotion in South Africa [22-24]. There is a
lack of evidence that such a community (church-based)
lifestyle intervention to lower diabetes and hypertension
risk is effective in an African setting. Therefore, a cluster
randomized controlled implementation trial to control
high normal blood pressure and/or high normal blood
glucose in church members in South Africa is proposed.
This proposed study will also identify culturally and
regionally specific approaches (and constraints) to the
translation of the key elements of the lifestyle arm of
the Diabetes and Hypertension Prevention Programme,
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models for the delivery of physical activity and dietary
interventions in a community setting (churches).
Aim of the study
The aim of this study is to study the efficacy of a commu-
nity (church) -based lifestyle intervention programme to
control high normal blood pressure and/or high normal
blood glucose in church members in a randomized con-
trolled trial in Gauteng, South Africa.
Objectives of the study
1. To measure non-communicable disease profile,
including hypertension and diabetes, health behaviours,
weight management and psychological distress of
church members;
2. To measure the reduction of blood glucose and
blood pressure levels after the intervention;
3. To prevent the development of impaired glucose
tolerance and hypertension;
4. To compare health behaviours, weight management
and psychological distress, blood glucose and blood
pressure levels between the intervention and controlFigure 1 Study design.groups, and within group during 6, 12, 24 and
36 months during and post intervention.
Methods/Design
Study design
The study is a cluster randomized controlled evaluation
of a group-based programme, implemented and reported
in accordance with the requirements of the CONSORT
statement [25] and its extension to cluster randomized trials
[26]. From community settings (churches) in Ga-Rankuwa
and Soshanguve, 12 churches will be randomly selected
for inclusion in the study; 6 churches will be intervention
and 6 churches will be control sites (see Figure 1).
Study hypotheses
 Individuals receiving lifestyle intervention will have a
greater reduction in systolic blood pressure,
compared with the individuals receiving a health
education leaflet only (control group).
 Individuals receiving lifestyle intervention will have a
greater reduction in blood glucose levels, compared
with the individuals receiving a health education
leaflet only (control group).
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Inclusion criteria
Churches Churches having a church building and hav-
ing at least 100 church members in the locations of
Ga-Rankuwa and Soshanguve will be included in the
study.
Church members Males and females, aged from 40–65
years, who visit the church, and having been diagnosed
with pre-diabetes and/or prehypertension will be in-
cluded in the study.
Exclusion criteria
Church members Church members under the age of 40
and above 65 years will not be included. In addition, all
individuals with previous diagnosis of heart diseases,
previous diagnosis of hypertension and/or type 2 dia-
betes, unstable pulmonary disease, history of alcoholism,
drug abuse, or other psychiatric problems that are likely
to limit compliance to the study, orthopaedic or rheuma-
tologic disease (i.e. severe rheumatoid arthritis), already
enrolled in a clinical research trial, and having kidney dis-
ease will be excluded.
Randomisation
A list of the names of churches in each village/ward will
be obtained. The church sites will be randomized into
intervention and control sites to prevent contamination.
Randomisation will be conducted using a secure remote
randomization service. We believe that there will not be
any contamination between the experimental and con-
trol groups since religious leaders and small group
church members will stay nearby their church area. The
control and intervention churches will not be matched.
There are about 452 Christian churches in Soshanguve
and Ga-Rankuwa [27]. In more than half of the churches
(52%) church members meet in a church building, more
than 70% have 100 or more church members and more
than 80% of the church members attend church at least
once a week [27].
Blinding
Church leaders will be informed that their assignment to
conditions is random, and that different churches will
receive different types of interventions. Random assign-
ment will occur prior to the baseline assessment to assure
that recruitment and assessment staff (research assistant
nurses) remains blind to condition assignments.
Procedure
After randomization, baseline measurements will occur.
Recruitment of the programme participants will take
place in 12 churches by specially trained research assistantnurses. Church members will be screened for prehyper-
tension and prediabetes by the research assistant nurses.
Step 0: Pre-screening
All church members will pass brief pre-screening questions
to meet the Inclusion Criteria: 1) age from 40–65 years,
2) willingness to participate in the screening programme.
Step 1: Screening for prehypertension and pre-diabetes
(at churches)
The participants will be recruited on Saturday and
Sunday after the worship activities. Research assistant
nurses will be trained for 1 week on risk factors, data
collection and research process. They will screen church
members in the church area (by putting up a tent with 4
sides wall), using a diabetes risk screen and blood pres-
sure assessment after informed consent has been taken
for study participation. Prehypertension will be defined
as blood pressure between 120-139/80-89 mmHg [28].
Blood pressure (BP) is measured with a validated auto-
mated digital BP monitor (BpTRU) based on South African
guidelines [29] three times at two different visits each, a
week apart. Prediabetes is initially assessed with the Dia-
betes Risk Score Tool. The risk status is determined by a
risk factor questionnaire developed on the basis of epi-
demiological studies [30,31]. A score of 15 or more will be
used as a recruitment criterion. High risk equals have an
estimated one in three chance of getting the disease dur-
ing the following 10 years. In the absence of a diabetes risk
screen developed in an African population, the Finnish
diabetes risk score (FINDRISC) questionnaire will be used
[30,31]. In a recent systematic review of risk scores based
on self-reported or available clinical data to detect undiag-
nosed type 2 diabetes found that “An important, but ten-
tative conclusion (given the small number of studies) is
that there is no reason to believe that risk scores in low
and middle income settings perform differently compared
to high income settings” [32], p. 382.
After completion of the face-to-face administered dia-
betes risk screen, the research assistant nurse will calcu-
late the risk score and provide the results to the client.
Likewise, church member’s blood pressure will be mea-
sured by a research assistant nurse and the results pro-
vided to the client. Clients who score less than 15 on the
diabetes risk screen are provided with a lifestyle educa-
tion pamphlet in English and SeTswana explaining the
benefits of a healthy diet and exercise. Likewise, clients
with a normal blood pressure are provided with a life-
style education pamphlet explaining the benefits of a
healthy diet and exercise.
Clients who score 15 or more on the diabetes risk
screen have elevated diabetes risk. Likewise, clients with
a blood pressure between 120-139/80-89 mmHg are at
elevated risk for hypertension. The research assistant
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study (Step II). The appointment will be made for the
following week at the churches and fasting procedures
are explained.
Step II: Confirmatory testing
A professional nurse will measure blood pressure (three
times) and collect fasting venous blood samples from
the participants for fasting plasma glucose (FPG) and
Lipid profile test. An appointment will be made to re-
ceive their results after one week and to recruit into the
trial. The Eligibility for Step III are: had high normal
blood pressure determined as a seating resting systolic
blood pressure between 120 and 139 mmHg and/or a
diastolic blood pressure of 80–89 mmHg, and/or a fast-
ing glucose level between 6.1 and 6.9 mmol/l and agreed
to participate over a 36-month period (2nd inform con-
sent (for intervention)). Patients with type 2 diabetes
and/or hypertension exit the study and are referred for
medical management (see Figure 1).
The study intervention will be conducted in church
buildings led by trained health promoters (details in the
intervention section).
Consent
Consent to participate will be obtained in a 3-stage
process. Research assistant nurses will initially ask for in-
formed consent to conduct a health screen (diabetes risk
screen and blood pressure test) and collect basic infor-
mation and check eligibility to take part. No identifiable
information will be collected at this stage. Patients who
score positive on the diabetes risk screen and/or have
high normal blood pressure, will have the study ex-
plained to them verbally and in writing (using the pa-
tient information sheet). Informed consent will now be
obtained for stage 2 of the study for confirmatory testing
of pre-diabetes and/or pre-hypertension. At this second
stage, which will include permission to give the contact
details to the research assistant nurses staff, and partici-




All the church members randomized and allocated to
the control group will complete the baseline and follow-
up measures, receive standard care and a lifestyle educa-
tion pamphlet on healthy diet and exercise benefits.
Lifestyle intervention
In the 6 lifestyle intervention study churches two lay
health promoters per church will be trained for two
weeks with a standardized training programme, trainingmanuals, and practical exercises. In each church the lay
health promoter(s) is expected to start and run 4–5 sup-
port groups (6–8 members per group) over the project
period. The intervention model used is based on a Finnish
diabetes prevention implementation study [33,34] and in-
cludes components of the PREMIER study [11,35]. Briefly,
the programme consists of six two-hour group sessions fa-
cilitated by trained lay health promoters [34]. They will re-
ceive two weeks of training with a standardized training
programme, training manuals, and practical exercises.
The first five sessions will extend over 8 weeks, with 2-
week intervals in between sessions. The last session will
take place at 6–8 months [34]. The sessions will be facili-
tated by specially trained lay health promoters, dieticians
and physiotherapists. The group counselling sessions pro-
vide individuals with dietary and physical activity guidance
based on the South African food-based dietary guidelines
for adults (South African food-based dietary guidelines)
[36] and South African physical activity recommendations
[37]. The Health Action Process Approach (HAPA) model
[38] and self-regulation theory [39] are used to set individ-
ual goals and motivate participants to progress from
intention to actual behaviour change to accomplish the
diet and physical activity goals of the programme [34].
Programme goals include seven specific goals related to
diet and physical activity [35,40]. The goals are: (1) no
more than 30 per cent of total energy from fat; (2) no
more than 10 per cent of total energy from saturated fats;
(3) at least 15 g/1000 kcal fibre; (4) at least 30 min/day
moderate intensity physical activity; (5) at least 5 per cent
reduction of present body weight, (6) limit daily sodium
intake to ≤2400 mg per day and (7) the goal for alcohol in-
take was ≤2 drinks/day for men and ≤ 1 drink/day for
women [35,40]. The lifestyle intervention content areas
[11,33-35] are summarized in Table 1.
Assessment and intervention quality assurance
Assessment and intervention quality assurance procedures
ensure that project activities are standardized across the
churches and across the cohorts and that assessment and
intervention process data are collected accurately. To achieve
this, standardized protocols, procedures, and training man-
uals are prepared, and the staff is systematically trained in
their use. In addition, the performance of the assessors
and programme implementers is routinely monitored by
the research coordinators. This will require the develop-
ment of mechanisms for determining that adequate levels
of competence have been attained by those who have re-
ceived training and that their continuing performance does
not fall below these levels. A random sample of group ses-
sion interactions will be tape-recorded and analysed for that
purpose. Feedback will be provided to the field work staff
and protocol deviations or other problems addressed and
corrected in a timely manner.
Table 1 Lifestyle intervention contents
Session Major intervention content
1 -Lifestyle influence health, diabetes, hypertension, risk factors
and development, effects, prevention
-Goals, planning, homework and other exercises, including
sensible alcohol use
-Homework assignments: monitoring own behaviour with
food diary (including identifying sodium content of foods) and
physical activity schedule
2 -Returning of food diaries
-Comparison of own habits with the diet and physical activity
goals sufficient for prevention, Role modelling, analysis and
re-attribution
-Homework assignments: preparation for goal setting,
monitoring physical activity and eating habits
3 -Feedback from the physical activity schedule
-Goal planning
-Homework assignments: feedback and re-enforcement;
monitoring physical activity and eating habits
4 -Feedback based on findings from food diaries
-Education on how to eat healthy?
-Goal planning, Goal setting
-Homework assignments: positive feedback in getting social
support; monitoring physical activity and eating habits
5 -Evaluating and refining the goals
-Routines, changed; intermediate goals
-Exercise: how to overcome barriers, how to use resources in
maintaining the behaviour changes
-Homework assignments: monitoring physical activity and
eating habits
6 -Evaluating the goals
-Routines, changed; analysis and re-attribution of success and
failure
-Future goals and evaluation
Table 2 Measures
Q1-Q5 = Questionnaires: components of the questionnaire include:
• Socio-demographic background, Non-communicable diseases, Tobacco
use, Physical activity, Food frequency questionnaire, Alcohol use, Dietary
behaviour, Dietary practices, Weight management and Perceived body
image, and Psychological distress
• Type II Diabetes Risk Screening
A1-A5 = Anthropometric and blood pressure measurements
• Weight will be measured on a digital scale to the nearest 0.1 kg in
light clothes and without shoes
• Height will be measured without shoes to the nearest centimeter
• Waist circumference will be measured (to the nearest 0.1 cm)
• twice midway between the lowest rib and iliac crest and the mean
value will be used
• Hip circumference will be measured twice at the largest part of the
hip, the mean value will be used
• Body Composition: will be measured using Body Stats machine
• Blood pressure (BP) is measured with a validated automated digital
BP monitor (BpTRU) based on South African guidelines [29]
L1-L4 = Lab tests
• Fasting venous samples are drawn at the baseline, at three months,
12, 24 and 36 months. All participants are required to fast overnight
prior to each clinical test for a minimum of eight hours
• The following methods are used for blood chemistry: (1) serum total
cholesterol: (2) HDL-LDL cholesterol, (3) triglycerides
• The plasma glucose and lipid profile determinations are carried out
using a uniform glucose oxidase-peroxidase and a cholesterol
oxidase-phenol aminophenazone (CHOD-PAP) method, respectively
Table 3 Study time line and data collection
Q1 Q2 Q3 Q4 Q5
L1 L2 L3 L4
A1 A2 A3 A4 A5
I1-I4 I5 I6
0 months 1 month 6 ms# 8 ms 12 ms 24 ms 36 ms
#in intervention group only.
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The primary outcomes and measures include 1) the re-
duction in systolic blood pressure after the intervention
and 2) the reduction in blood glucose levels after the
intervention.
The secondary outcomes and measures include 1)
anthropometric measures: body weight, height (for
BMI) and waist-to-hip-ratio; body composition 2) lipid
levels: total cholesterol, LDL- and HDL-cholesterol, tri-
glycerides; 3) behavioural measures (diet, physical ac-
tivity, tobacco, alcohol, weight and stress); and 4) blood
lipid profiles. Measurements will occur at baseline, 6-
months, 12-months and 36-months post intervention
(Figure 1). The primary and secondary outcome mea-
sures are described as questionnaires, anthropometric
and blood pressure measurements and lab tests (see
Tables 2 and 3).I1-I6 = Intervention sessions (see above)
The fidelity of programme delivery is measured with a
facilitator questionnaire after each completed interven-
tion period.
Sample size calculation
As reviewed by Petrella et al. [41], data from previous
intervention studies found a change in systolic blood pres-
sure after the intervention between 5.32 and 5.92 mmHg
providing a 90% power [34], while a reduction of blood
glucose levels of 0.1 to 0.3 mmol. are noted as important
in terms of the risk for the development of type 2 diabetes
[35]. The Trial Protocol Tool for RCTs software (2004)
was used to calculate sample size at power 90%, average
cluster size 20, A median intracluster correlation (ICC) of
0.005 (average Standard Deviation 0.3), as suggested by
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cess rate in achieving suitable recordings in two test sites
the minimum unadjusted sample size is 96 and number of
clusters per group is 6. From previous similar researches,
the dropout rate of approximately 20%, hence recruit
120 subjects; for preventing of loss of two follow up, we
increase to 150 subjects in 6 clusters per treatment arm.
Intervention evaluation and statistical analysis
The RE-AIM (Reach, Efficacy/Effectiveness, Adoption,
Implementation, and Maintenance) evaluation frame-
work for complex implementation trials will be utilized
to analyze the reach, effectiveness, adoption, and imple-
mentation of the intervention [18]. Nutritional intake is
analysed by a registered dietitian using Nutrica software
(Norfoods, 2000). Evaluation will be conducted in terms
of attainment of the diet and physical activity goals;
changes in the most significant automated biological
markers (blood glucose levels, cholesterol, blood pres-
sure, weight and waist circumference); and changes in
the determinants of behaviour.
The statistical analysis will include differences among
the subjects’ characteristics in clinical, behavioural, and
physiological outcome measures using analysis of vari-
ance (ANOVA). Interactions and/or a specific age, gen-
der, or clinical variable differences will be examined
using Tukey’s post hoc analyses. If a group difference be-
tween a potentially confounding variable is observed at
limit differences in a key outcome, analysis of covariance
(ANCOVA) will be performed with the potentially con-
founding variable serving as the covariant. Relations of
interest will be initially identified by univariate correlation
analysis. Independent correlations among the dependent
variables will be determined using partial correlation
analyses and/or conventional multivariate step-wise re-
gression analysis. In all cases, probability levels will be
p < 0.05.
Ethical and research governance approval
We have received ethical approval from the University
of Limpopo MEDUNSA Research and Ethics Committee
(Project number: MREC/H236/2012:IR).
Project timescales
The study will run for a period of 46 months beginning
in January 2014 to October 2017.
Discussion
This integrative lifestyle intervention trial for both the
reduction of diabetes and hypertension risk offers the
unique opportunity to evaluate the effect of a community
(church) -based intervention delivered by trained lay
health promoters targeting a high risk population. The in-
tegration of a lifestyle intervention for both the reductionof diabetes and hypertension risk and evaluating the ef-
fectiveness of this intervention in a community-based
setting is both innovative and can facilitate research
translation into primary health care practice. Moreover,
this intervention utilizes community health workers to
enhance lifestyle modification for the reduction of both
diabetes and hypertension risk through group sessions,
which can be easily adapted in real world settings. This
study will present a new analysis of the effectiveness a
community (church)-based lifestyle intervention programme
to control high normal blood pressure and/or high normal
blood glucose in a low and middle income setting. If data
confirm our hypothesis, this may help policy makers to in-
crease resources in prevention rather than treatment. It is
important to consider that the study data will be collected
from a real life community setting.
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